Characterization of Korean native goat lactoferrin

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 123, Issue 2, 1999, Pages 201-208

  Nam, Myoung Soo ^a   Shimazaki, Kei Ichi ^a   Kumura, Haruto ^a   Lee, Kyung Kwang ^b   Yu, Dae Yeul ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Circular dichroism; Conformation; Heparin binding affinity; Iron binding protein; Korean native goat; Lactoferrin; Milk protein; Secondary structure

Indexed keywords

HEPARIN; LACTOFERRIN; SYNTHETIC PEPTIDE;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CIRCULAR DICHROISM; COLOSTRUM; GOAT; ION EXCHANGE CHROMATOGRAPHY; IRON BINDING CAPACITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN ISOLATION; PROTEIN PURIFICATION; WESTERN BLOTTING;

BOVINAE; CAPRA HIRCUS;

EID: 0342527391     PISSN: 03050491     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-0491(99)00060-7     Document Type: Article

References (26)

1. Bezault J, Bhimani R, Wiprovnick J, Furmanski P. Human lactoferrin inhibits growth of solid tumors and development of experimental metastases in mice. Cancer Res 1994;54:2310-2.
2. Blackberg L, Hernell O. Isolation of lactoferrin from human whey by a single chromatographic step. FEBS Lett 1980;109:180-4.
3. Blankemeyer-Menge B, Nimtz M, Frank R. An efficient method for anchoring Fmoc-amino acids to hydroxyl-functionalised solid supports. Tetrahedron Lett 1990;31:1701-4.
4. Bollage DM, Rozycki MD. In: Bollage DM, editor. Protein methods, 2nd. New York: Wiley-Liss, 1996:107-54.
5. Broxmeyer HE. Suppression of mouse myelopoiesis by administration of human lactoferrin in vivo and the comparative action of human transferrin. Blood 1983;61:982-93.
6. De Sousa M, Breedvelt F, Pynesiue-Trenthan R, Trenthan P, Lum J. Iron, iron-binding protein and immune system cells. Ann NY Acad Sci 1988;526:310-22.
7. Feingold D, Roden L, Forsee T, Jacobsson I, Jensen J, Lindahl U, Malmstrom A, Prihar H. In: Lundblad RL, Brown WV, Mann KG, Roberts HR, editors. Heparin biosynthesis, in Chemistry and Biology of Heparin. Elsevier North Holland, Inc, 1981:157-71.
8. Gahr M, Speer CP, Damerau B, Sawatzki G. Influence of lactoferrin on the function of human polymorphonuclear leukocytes and monocytes. J Leukocyte Biol 1991;49:427-33.
9. Le Provost F, Nocart M, Guerin G, Martin P. Characterization of the goat lactoferrin cDNA : Assignment of the relevant locus to bovine U12 synteny group. Biochem Biophys Res Commun 1994;203:1324-32.
10. Lee TH, Shimazaki K, Yu SL, Nam MS, Kim SJ, Lee KK, Yu DY. Polymorphic sequence of Korean native goat lactoferrin exhibiting greater antibacterial activity. Animal Genet 1997;28:367-9.
11. Lim JW. The composition of neutral lipids and its fatty acid of Korean native goats' milk. Korean J Anim Sci 1984;26:631-9.
12. Masson PL, Heremans JF. Studies on lactoferrin in milk from different species. Comp Biochem Physiol 1971;39B:119-29.
13. Masson PL, Heremans JF. Studies on lactoferrin, the iron-binding protein of secretions. Protides Biol Fluids 1966;14:115-24.
14. Pierce A, Colavizza D, Benaissa M, Maes P, Tartar A, Montreuil J, Spik G. Molecular cloning and sequence analysis of bovine lactotransferrin. Eur J Biochem 1991;196:177-84.
15. Sawatzki G, Rich IN. Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 1989;15:371-85.
16. Shau H, Kim A, Golub H. Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin. J Leukocyte Biol 1992;51:343-9.
17. Shimazaki K, Kawano N, Yoo YC. Comparison of bovine, sheep and goat milk lactoferrins in their electrophoretic behavior, conformation, immunochemical properties and lectin reactivity. Comp Biochem Physiol 1991;98B:417-22.
18. Shimazaki K, Tazume T, Uji K, Tanaka M, Kumura H, Mikawa K, Shimo-oka T. Properties of a heparin-binding peptide derived from bovine lactoferrin. J Dairy Sci 1998;81:2841-9.
19. van Berkel PHC, Geerts MEJ, van Veen HA, Mericskay M, de Boer HA, Nuijens JH. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem J 1997;328:145-51.
20. Wang CS, Chang WY, Kloer HU. Comparative studies on the chemical and immunochemical properties of human milk, human pancreatic juice and bovine milk lactoferrin. Comp Biochem Physiol 1984;78B:575-80.
21. Weinberg ED. Iron with holding : a defence against infection and neoplasisa. Physiol Rev 1984;64:65-102.
22. Wu HF, Lundblad RL, Church FC. Neutralization of heparin activity by neutrophil lactoferrin. Blood 1995;85:421-8.
23. Wu HF, Monroe DM, Church FC. Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch Biochem Biophy 1995;317:85-92.
24. Yang JT, Wu C-S, Martinez HM. Calculation of protein conformation from circular dichroism. In: Hirs CH, Timasheff SN, editors. Methods in Enzymology, vol. 130. New York: Academic Press, 1986:208-69.
25. Yoo YC, Watanabe S, Watanabe R, Hata K, Shimazaki K, Azuma I. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice. Jpn J Cancer Res 1997;88:184-90.
26. Zou S, Magura CE, Hurley WL. Heparin-binding properties of lactoferrin and lysozyme. Comp Biochem Physiol 1992;103B:889-95.